RECRUITING

The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This phase II trial test the effectiveness and safety of a single-port robotic device (the da Vinci single port \[SP\]1098) for use in abdominal and pelvic surgeries. The da Vinci SP1098 robotic device can be used to perform less invasive surgeries that allow entry into the body through a single, small incision. The use of this device during surgery may allow surgeons to perform complex procedures that result in less pain, fewer complications and side effects, and improved recovery.

Official Title

Phase II Study of the Da Vinci Single Port (SP) Robotic System for Abdominal and Pelvic Procedures

Quick Facts

Study Start:2024-04-26
Study Completion:2025-01-27
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05672368

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Documented informed consent of the participant and/or legally authorized representative
  2. * Any patient scheduled to undergo robot-assisted abdominal or pelvic procedures
  3. * Age \> 18 years
  1. * Body mass index (BMI) \> 45
  2. * Contraindications to minimally invasive surgery including chronic obstructive pulmonary disorders
  3. * Past history of failed attempt of minimally invasive abdominal or pelvic surgery

Contacts and Locations

Principal Investigator

Mehdi Moslemi-Kebria
PRINCIPAL_INVESTIGATOR
City of Hope Comprehensive Cancer Center

Study Locations (Sites)

City of Hope Comprehensive Cancer Center
Duarte, California, 91010
United States

Collaborators and Investigators

Sponsor: City of Hope Medical Center

  • Mehdi Moslemi-Kebria, PRINCIPAL_INVESTIGATOR, City of Hope Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-26
Study Completion Date2025-01-27

Study Record Updates

Study Start Date2024-04-26
Study Completion Date2025-01-27

Terms related to this study

Additional Relevant MeSH Terms

  • Disease or Disorder